Improve Your Regulatory Submissions

By submitting this form, you agree to receive communication regarding this content. You also agree to receive our quarterly newsletter and occasional messages featuring IPM news and insights. You can opt out anytime. View our full Privacy Policy.

Improve Your Regulatory Submissions by Setting, Tracking, and Using the Right Metrics

With the growing complexity of clinical trials and increasing pressure to get to market faster, timelines are under more scrutiny than ever. Benchmarking regulatory submission processes against industry standards can help identify opportunities to improve business performance. It can also help manage executive expectations. The challenge is that industry benchmarks are difficult to find.

The regulatory experts at Integrated Project Management help fill the gap with metrics collected while leading more than 100 submission teams. 

Download the complete article for:

  • Guidance on establishing submission metrics
  • Detailed milestones and related measurements
  • Top-line metrics from more than 100 submission teams
  • Five key factors for accurately projecting a submission date

Susan Carino

 

Susan Carino is a Principal Consultant with more than 25 years of industry experience in R&D across numerous therapeutic areas. She specializes in global regulatory strategy development and regulatory project management for submissions. She leads diverse cross-functional program teams engaged in complex product development of new pharmaceuticals, biologics, medical devices, and in vitro diagnostic tests.

 

 

Troy Kinney

 

Troy Kinney is a Project Management Consultant with more than 30 years of experience in program, engineering, and operations management. He works in the life sciences industry on pharmaceutical, medical device, and diagnostic instrument regulatory programs. 

 

 

 

Greg Palagi

 

Greg Palagi is a Project Management Consultant with more than 10 years of experience in product development and engineering in the life science industry. He leads teams that specialize in the development of medical devices and medical device regulatory submissions.